The 2026 Washington legislative session changed policies affecting women’s health – and is already reshaping how health tech companies think about data, access, and product strategy.
Join our experts and thought leaders for insights on:
Key bills and policy signals that matter
How companies are interpreting and responding
Implications for strategy, risk, and opportunity
We’ll anchor the discussion in specific legislation that passed (and what didn’t) — and step back to examine broader implications for product, data, operations, and innovation.
Designed for founders, operators, investors, and advisors working at the intersection of health, technology, and policy — this is a chance to understand what’s changing and what to do next alongside others already thinking through it.